Hims & Hers Health/HIMS

$9.61

-4.18%
-
1D1W1MYTD1YMAX

About Hims & Hers Health

Hims & Hers Health, Inc. is a consumer-first platform focused on providing personalized health and wellness experiences to consumers. The Company's digital platform enables access to treatments for a range of conditions, including those related to sexual health, hair loss, dermatology, mental health and primary care. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. The prescriptions are fulfilled online through licensed pharmacies on a subscription basis. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services that promote lifelong health and wellness. The Company's products include shampoo, conditioner, biotin gummies, anti-aging cream, vitamin c serum, acne cream and moisturizer. Its products are sold in tens of thousands of retail locations in the United States.
Ticker
HIMS
Sector
Healthcare
Trading on
NYSE
Industry
Biotechnology & Drugs
CEO
Andrew Dudum
Employees
651
Headquarters
San francisco, United States

HIMS Metrics

BasicAdvanced
$2.13B
Market cap
-
P/E ratio
-$0.17
EPS
0.79
Beta
-
Dividend rate

What the Analysts think about HIMS

Analyst Ratings

Majority rating from 11 analysts.
Buy

Price Targets

Average projection from 11 analysts.
13.01% upside
High $15.00
Low $7.00
$9.61
Current price
$10.86
Average price target

HIMS Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-3.3% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$226.6M
8.99%
Net income
$-7.5M
5.63%
Profit margin
-3.3%
-3.23%

HIMS Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 27.27%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.05
-$0.05
-$0.03
-$0.04
-
Expected
-$0.07
-$0.07
-$0.05
-$0.03
-$0.02
Surprise
-25%
-30%
-44.74%
27.27%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Hims & Hers Health stock

Buy or sell Hims & Hers Health stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing